Tumor Necrosis Factor Blocker [EPC] - N0000175610

Pharmacologic Class Information

Pharmacologic Code N0000175610
Pharmacologic Name Tumor Necrosis Factor Blocker
Pharmacologic Uses
  • tumor necrosis factor (TNF) blocker
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Tumor Necrosis Factor Blocker

The table contains 66 products whose active ingredient are classified under the same pharmacologic class Tumor Necrosis Factor Blocker [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0006-4305Renflexis Non-Proprietary Name: InfliximabInjection, Powder, Lyophilized, For SolutionIntravenousMerck Sharp & Dohme LlcACTIVE
0069-0809Inflectra Non-Proprietary Name: Infliximab-dyybInjection, Powder, Lyophilized, For SolutionIntravenousPfizer Laboratories Div Pfizer IncACTIVE
50090-4590Enbrel Non-Proprietary Name: EtanerceptSolutionSubcutaneousA-s Medication SolutionsACTIVE
50090-6411Amjevita Non-Proprietary Name: Adalimumab-attoInjectionSubcutaneousA-s Medication SolutionsACTIVE
50090-6428Amjevita Non-Proprietary Name: Adalimumab-attoInjectionSubcutaneousA-s Medication SolutionsACTIVE
50090-6704Hadlima Non-Proprietary Name: Adalimumab-bwwdSolutionSubcutaneousA-s Medication SolutionsACTIVE
50090-6705Hadlima Non-Proprietary Name: Adalimumab-bwwdSolutionSubcutaneousA-s Medication SolutionsACTIVE
50090-6706Hadlima Non-Proprietary Name: Adalimumab-bwwdSolutionSubcutaneousA-s Medication SolutionsACTIVE
50090-6707Hadlima Non-Proprietary Name: Adalimumab-bwwdSolutionSubcutaneousA-s Medication SolutionsACTIVE
50474-710Cimzia Non-Proprietary Name: Certolizumab PegolInjection, SolutionSubcutaneousUcb, Inc.ACTIVE
55513-399Amjevita Non-Proprietary Name: Adalimumab-attoInjectionSubcutaneousAmgen IncACTIVE
55513-400Amjevita Non-Proprietary Name: Adalimumab-attoInjectionSubcutaneousAmgen IncACTIVE
55513-410Amjevita Non-Proprietary Name: Adalimumab-attoInjectionSubcutaneousAmgen IncACTIVE
55513-411Amjevita Non-Proprietary Name: Adalimumab-attoInjectionSubcutaneousAmgen IncACTIVE
55513-413Amjevita Non-Proprietary Name: Adalimumab-attoInjectionSubcutaneousAmgen IncACTIVE
55513-479Amjevita Non-Proprietary Name: Adalimumab-attoInjectionSubcutaneousAmgen IncACTIVE
55513-480Amjevita Non-Proprietary Name: Adalimumab-attoInjectionSubcutaneousAmgen IncACTIVE
55513-481Amjevita Non-Proprietary Name: Adalimumab-attoInjectionSubcutaneousAmgen IncACTIVE
55513-482Amjevita Non-Proprietary Name: Adalimumab-attoInjectionSubcutaneousAmgen IncACTIVE
55513-670Avsola Non-Proprietary Name: Infliximab-axxqInjection, Powder, Lyophilized, For SolutionIntravenousAmgen IncACTIVE
57894-030Remicade Non-Proprietary Name: InfliximabInjection, Powder, Lyophilized, For SolutionIntravenousJanssen Biotech, Inc.ACTIVE
57894-070Simponi Non-Proprietary Name: GolimumabInjection, SolutionSubcutaneousJanssen Biotech, Inc.ACTIVE
57894-071Simponi Non-Proprietary Name: GolimumabInjection, SolutionSubcutaneousJanssen Biotech, Inc.ACTIVE
57894-160Infliximab Non-Proprietary Name: InfliximabInjection, Powder, Lyophilized, For SolutionIntravenousJanssen Biotech, Inc.ACTIVE
57894-350Simponi Aria Non-Proprietary Name: GolimumabSolutionIntravenousJanssen Biotech, Inc.ACTIVE
58406-010Enbrel Non-Proprietary Name: EtanerceptSolutionSubcutaneousImmunex CorporationACTIVE
58406-021Enbrel Non-Proprietary Name: EtanerceptSolutionSubcutaneousImmunex CorporationACTIVE
58406-032Enbrel Non-Proprietary Name: EtanerceptSolutionSubcutaneousImmunex CorporationACTIVE
58406-044Enbrel Non-Proprietary Name: EtanerceptSolutionSubcutaneousImmunex CorporationACTIVE
58406-055Enbrel Non-Proprietary Name: EtanerceptSolutionSubcutaneousImmunex CorporationACTIVE
58406-435Enbrel Non-Proprietary Name: EtanerceptSolutionSubcutaneousImmunex CorporationACTIVE
58406-445Enbrel Non-Proprietary Name: EtanerceptSolutionSubcutaneousImmunex CorporationACTIVE
58406-455Enbrel Non-Proprietary Name: EtanerceptSolutionSubcutaneousImmunex CorporationACTIVE
58406-456Enbrel Non-Proprietary Name: EtanerceptSolutionSubcutaneousImmunex CorporationACTIVE
61314-327Adalimumab Non-Proprietary Name: Adalimumab-adazInjection, SolutionSubcutaneousSandoz IncACTIVE
61314-454Hyrimoz Non-Proprietary Name: Adalimumab-adazInjection, SolutionSubcutaneousSandoz IncACTIVE
61314-473Hyrimoz Non-Proprietary Name: Adalimumab-adazInjection, SolutionSubcutaneousSandoz IncACTIVE
61314-476Hyrimoz Non-Proprietary Name: Adalimumab-adazInjection, SolutionSubcutaneousSandoz IncACTIVE
61314-509Hyrimoz Non-Proprietary Name: Adalimumab-adazInjection, SolutionSubcutaneousSandoz IncACTIVE
65219-554Idacio Non-Proprietary Name: AdalimumabInjection, SolutionSubcutaneousFresenius Kabi Usa, LlcACTIVE
65219-556Idacio Non-Proprietary Name: AdalimumabInjection, SolutionSubcutaneousFresenius Kabi Usa, LlcACTIVE
70114-210Yusimry Non-Proprietary Name: Adalimumab-aqvhInjection, SolutionSubcutaneousCoherus Biosciences IncACTIVE
70114-220Yusimry Non-Proprietary Name: Adalimumab-aqvhInjection, SolutionSubcutaneousCoherus Biosciences IncACTIVE
72511-400Amjevita Non-Proprietary Name: Adalimumab-attoInjectionSubcutaneousAmgen Usa Inc.ACTIVE
72511-482Amjevita Non-Proprietary Name: Adalimumab-attoInjectionSubcutaneousAmgen Usa Inc.ACTIVE
72606-022Adalimumab Non-Proprietary Name: Adalimumab-aatyInjectionSubcutaneousCelltrion Usa, Inc.ACTIVE
72606-023Yuflyma Non-Proprietary Name: AdalimumabInjectionSubcutaneousCelltrion Usa, Inc.ACTIVE
72606-024Yuflyma Non-Proprietary Name: AdalimumabInjectionSubcutaneousCelltrion Usa, Inc.ACTIVE
72606-025Zymfentra Non-Proprietary Name: Infliximab-dyybInjectionSubcutaneousCelltrion Usa Inc.ACTIVE
72606-030Yuflyma Non-Proprietary Name: AdalimumabInjectionSubcutaneousCelltrion Usa, Inc.ACTIVE
72606-040Adalimumab Non-Proprietary Name: Adalimumab-aatyInjectionSubcutaneousCelltrion Usa, Inc.ACTIVE
72606-041Adalimumab Non-Proprietary Name: Adalimumab-aatyInjectionSubcutaneousCelltrion Usa, Inc.ACTIVE
72606-047Zymfentra Non-Proprietary Name: Infliximab-dyybInjectionSubcutaneousCelltrion Usa Inc.ACTIVE
78206-162Renflexis Non-Proprietary Name: InfliximabInjection, Powder, Lyophilized, For SolutionIntravenousOrganon LlcACTIVE
78206-183Hadlima Non-Proprietary Name: Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
78206-184Hadlima Non-Proprietary Name: Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
78206-185Hadlima Non-Proprietary Name: Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
78206-186Hadlima Non-Proprietary Name: Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
78206-187Hadlima Non-Proprietary Name: Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
83457-100Hyrimoz Non-Proprietary Name: Adalimumab-adazInjection, SolutionSubcutaneousCordavis LimitedACTIVE
83457-101Hyrimoz Non-Proprietary Name: Adalimumab-adazInjection, SolutionSubcutaneousCordavis LimitedACTIVE
83457-102Hyrimoz Non-Proprietary Name: Adalimumab-adazInjection, SolutionSubcutaneousCordavis LimitedACTIVE
83457-103Hyrimoz Non-Proprietary Name: Adalimumab-adazInjection, SolutionSubcutaneousCordavis LimitedACTIVE
83457-107Hyrimoz Non-Proprietary Name: Adalimumab-adazInjection, SolutionSubcutaneousCordavis LimitedACTIVE
83457-108Hyrimoz Non-Proprietary Name: Adalimumab-adazInjection, SolutionSubcutaneousCordavis LimitedACTIVE
83457-113Hyrimoz Non-Proprietary Name: Adalimumab-adazInjection, SolutionSubcutaneousCordavis LimitedACTIVE